Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EHA 2019 /
Chemotherapy-free strategies in treating leukaemia

13th - 16th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.06.19
Views: 464
Rating:

Prof Robin Foa - University of Rome, Rome, Italy

Prof Robin Foa speaks to ecancer at the 2019 European Hematology Association (EHA) Annual Meeting about treatment alternatives to chemotherapy for leukaemia.

He explains that today there are many targeted treatments that are succesful, particularly with the help of minimal residual disease monitoring.

Prof Foa also highlights CAR-T as an area of excitement and a real step forward but that the treatment's high cost and restricted availability are current setbacks.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation